Hepatitis C in Advanced Chronic Kidney Disease: Addressing the High-Risk Patient - A Two-Part Series

This multi-activity series will address the clinical challenge of evaluating and treating Hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD). Content will describe the pathogenesis of HCV infection and its associations with CKD. Diagnostic modalities for HCV infection will also be discussed. The benefits and limitations of conventional antiviral regimens will be addressed. Recent clinical evidence for direct acting antivirals (DAAs) will also be included.

Supported by an educational grant from AbbVie. 

Target Audience

  • Physicians 
  • Pharmacists
  • Physician Assistants
  • Nurse Practitioners
  • Nurses 
  • Dietitians 
  • Social Workers

To access an activity in this series:

  1. Create an account/login
  2. Review the information on the "Overview" and "Accreditation" tabs before clicking "Register" 
  3. Click on the title of the module you wish to take
  4. Review information for this specific module before proceeding by clicking "Continue"
Acknowledgements:

Supported by an educational grant from AbbVie Inc. 

Course summary
Course opens: 
01/15/2018
Course expires: 
01/15/2019
Cost:
$0.00
Rating: 
5

Please see each individual activity for their accrediation and method of participation information. 

Available Credit

Accreditation Period

Course opens: 
01/15/2018
Course expires: 
01/15/2019
 
Status
Price
Title
$0.00Included
Please login or register for a PERC account to take this course.
$0.00Included
Please login or register for a PERC account to take this course.

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.